InvestorsHub Logo
Followers 16
Posts 193
Boards Moderated 0
Alias Born 08/15/2003

Re: None

Monday, 03/24/2014 2:07:07 PM

Monday, March 24, 2014 2:07:07 PM

Post# of 50668
One possibility -
Multicell Immunotheraupeutics is a private company listed as a subsidiary of MCET. It was once Astral. MCET acquired it and it's
patents back in 2007 I believe. (Don't hold me to that). The directors are the same as MCET.

Among the patents were MCT465, 475 and 485. (They were designated something else at the time). By keeping this subsidiary private. Multicell can control it's fate on a takeover attempt by holding the prize hostage.

Also, they could acquire the stock of MCET and not have to declare 10% ownership. Doesn't take too many 9.99% owners to amass
more that 50% of a companies stock. At these prices, a couple of million would do the trick.

JMHO -